Stock Events

Stock Events

AI Financial

$0.96

124

+$0.13+15.97% Today

Statistics

Day High

1

Day Low

0.83

52W High

0.98

52W Low

0.75

Volume

59,061

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Upcoming

Earnings

19MayExpected

Next

-0.14

0.19

0.53

0.86

Expected EPS

-0.14

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AIFC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Pfizer is a global pharmaceutical company that competes with JanOne in the development of treatments for various diseases, including those JanOne targets with its non-opioid pain management solutions.

Johnson & Johnson

Johnson & Johnson, through its pharmaceutical segment, competes in developing medications and treatments that can overlap with JanOne's focus areas, including pain management.

AbbVie operates in the pharmaceuticals sector, focusing on innovative therapies, directly competing with JanOne in areas like chronic pain treatment.

Merck is involved in the development and manufacturing of drugs that address serious health issues, competing with JanOne in the pharmaceutical space, especially in pain management solutions.

Teva- Pharmaceutical Industries

Teva Pharmaceutical Industries specializes in generic and specialty medicines, including pain management, making it a competitor to JanOne in the non-opioid pain relief market.

Novartis is a global healthcare company that produces drugs in various therapeutic areas, including pain, competing with JanOne's mission to offer alternative pain solutions.

Bristol-Myers Squibb

Bristol Myers Squibb is a biopharmaceutical company that develops medicines in several therapeutic areas, potentially competing with JanOne in the area of pain management.

Eli Lilly and Company focuses on pharmaceuticals in areas that could compete with JanOne, especially considering their work on pain and chronic conditions.

GlaxoSmithKline is a healthcare company that produces pharmaceuticals across various areas, including pain relief, making it a competitor to JanOne.

Sanofi is a global life sciences company that offers a broad range of medicines, including those for pain management, competing with JanOne's focus on non-opioid solutions.

Holdings

Regions

Sectors

About

ALT5 Sigma Corporation operates a next generation blockchain platform. It engages in the tokenization, trading, clearing settlement, payment, and safe keeping of digital assets. The company's products include ALT 5 Prime, an electronic over-the-counter trading platform to buy and sell digital assets; and ALT 5 Pay that enables payment processors to accept digital assets as payments, as well as make payment in digital assets. It is also involved in the developing of solutions for opioid crisis. The company was formerly known as JanOne Inc. and changed its name to ALT5 Sigma Corporation in July 2024. ALT5 Sigma Corporation was founded in 1976 and is based in Las Vegas, Nevada.

Show more...

CEO

Employees

16

Country

United States

ISIN

US47089W1045

Listings

0 Comments

Share your thoughts

FAQ

What is AI Financial stock price today?▼

The current price of AIFC is $0.96 USD — it has increased by +15.97% in the past 24 hours. Watch AI Financial stock price performance more closely on the chart.

What is AI Financial stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange AI Financial stocks are traded under the ticker AIFC.

When is the next AI Financial earnings date?▼

AI Financial is going to release the next earnings report on May 19, 2026.

How many employees does AI Financial have?▼

As of May 06, 2026, the company has 16 employees.

In which sector is AI Financial located?▼

AI Financial operates in the Other sector.

When did AI Financial complete a stock split?▼

AI Financial has not had any recent stock splits.